Drug Sponsors

CenterWatch Releases Special Report on Clinical Trial Development in Central and Eastern Europe

Friday, October 10, 2008

CenterWatch, a global source for clinical trials information, today announced the release of its latest report, Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials. The report explores the evolution of this region that has seen its growth in the industry triple in the last five years, making it the largest area for global clinical trial initiations outside of North America and Western Europe.

[Read More]

eClinical Technology News

Tuesday, March 18, 2008

Ft. Lauderdale, Fla.-based OmniComm Systems won a contract from Pleiad Devices, a medical device focused contract research organization. OmniComm will become a preferred vendor for Pleiad. The company will use OmniComm’s electronic data capture (EDC) product TrialMaster, initially for a trial studying an eye treatment. “Over the years, our team has had experience with most of the EDC vendors in the marketplace. TrialMaster is one of the best EDC products that we have seen and we look forward to offering our medical device customers this premier service,” stated Stephen Brandao, vice president of business development at Pleiad Devices.

[Read More]

Bilcare To Create Research Academy in India and Asia

Tuesday, June 5, 2007

India-based Bilcare Limited, a pharmaceutical packaging and clinical technology firm, together with the Association of Clinical Research Professionals (ACRP), have created the Bilcare Research Academy. The company will open 25 educational centers in India and Asia by 2010, investing $4.8 million. The first centers to open in India and Singapore, followed later by Thailand, Pakistan, Bangladesh, Sri Lanka, Indonesia and China.

[Read More]

Cost of Compliance Rising for AHCs

Thursday, May 31, 2007

The Association of Academic Health Centers (AAHC), a non-profit organization supports the nation’s academic health centers, has released a paper reporting that its members are allocating higher amounts of funds towards increasingly burdensome clinical trial compliance requirements. The AAHC placed investing in compliance as its top priority and called the requirements essential for ensuring safe and effective trials. However, the AAHC stated the cost of compliance is a national issue facing the entire academic health center (AHC) enterprise. The report said that for a one-year period, some AHCs reported compliance costs increased as much as 70%. The paper is called Investing in Clinical Trial Compliance.

[Read More]